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   The speci貸。 immune reactivities of leukocytes to tu皿or associated antigens and speci丘。．serum
immune reactivities of leukocytes to tumor associated antigens and specific serurn factors in cancer
patients were studied on I O urinary bladder carcinoma， 4 prostatic carcinoma， 3 renal carcinoma
and 10 control subjects．
   The specific reactivities were measured by means of leu］ ocyte adherence inhibition test（LAI）
following Halliday et al． and LAI index was calculated．
   Autologous and allogeneic crude extracts were prepared from resected bladder carcinoma and
prostatic sarcoma tissues for antigens． Tumor and normal tissues were hornogenized and centrifuged
at 20，000 g， 40C for 60 minutes． Supernate filtered by millipore filter （O．45 pt） was used as antigen．
Final concentration of tissue extracts was adjusted to 100 yg／ml of protein， that was optimal dose as
antlgen．
   Sera used in this experiment were taken frorn patients．with urinary bladder carcinoma before
and after operation， renal carcinoma， prostatic carcinoma and normal subjects．
   When leukocytes肋m patients with bladd．er carc｛no皿a were chaUenged against transitionaI
cell carcinoma extract（TCC－extract）， LAI index was about O．58． But leukocytes from normal subjects
or other patients with urological malignant diseases showed no reaction against TCC－extracts．
   The reaction of leukocytes from preoperative bladder carcinoma patients to TCC－extracts could
be blocked by sera from bladder carcinoma patients before operation． Otherwise the leukocytes’
from the sarne patient did not show LAI reaction against prostatic sarcoma extract and there was
no blocking effect of sera．
   The present study also demonstrated that sera from bladder carcinoma patients after operation，
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who were clinically tumor－free， could unblock the blocking effect of sera from bladder carcinoma
patients before Dperation． And it was shown that the blo6king ’and unblocking effects of sera from
bladder carcinoma patients might be exchanged each other on 3 to 6 months after operation．
  Immunolegical parameters and immunotherapy were discussed about urinary bladder carcinoma
Patlents．





































1 一2g ， Tumor mass or Normal tissue
       ；
   Washed by sterile saHne
       ，
   freezed at 一20℃，24hrs，
       ‘
     flnety chopped
       Eagle MEM（PC 105u／2． SM ’！OOmg／g）
       1 lo－lsme
     blade homogenizer 15’
       ；
    ・glass homogenizer 10’
       ，
   centrifugation 3000g， 40C， 30’
      ；
   supp． fatty tissue removed
       ，
   centrifugation 20000g， 40C． 60’
       ，
   supp， millipore filter （pore size O．45＃）
       ；
   determination of protein conc．
       ・
     stored at 一200C
























 incubate 37”C ． 90’
    ，
 leukocytes rich plasma
    i1200rpm， 10’
   cell pellet＄
西尾・ほか：膀胱癌・LAI test
    ； 1．5me of distilled water
    ： （lysis of remaining RBC）
  Washed thrice in Eagle MEM
    ，
  re－su＄pended in Eagle MEM（10％ FCS）
   Ieukocytes 2．0×107Zme    U
leukocyte O．05mg O．05 O．05
extract O．05me 一 ’
Serum O．05m2 O．05 一
medium O．05me O．1 O．15
     ；    ；   l
  preliminary incuhation 37“C， 30’， 5％ CO2
     ；   i   l
  introduced inta hemacytometer
     ；   ；   ；
  incubation in humid atomsF）here， 37℃， 60’． 5％ CO2
     s   i   ；
  counted nucleated ce：ls
     ；   ；   l
  gentiy washed the hernacytosneter in warm saSine
     ；   1   ；
  counted the remaining cefils
o，．
D Adherence．，；9／PelE［gE1） ：aini［III． Ceii ．number ×loo
      initiai cell number
      ％ Adherence present antigenLAI index ＝      ％ Adherence absent antigen












































Table 1． Activity of antigen on LAI
臨野yteS A…9・・   LAI indexSerum   （M±SD）
Bladcier
Carcinoma 1 TCC 1 F“C＄
（n＝10）
Normal










TCC ： transitienal celt carcinoma
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Table 2． ， Blocking effect of appropriate tumor





pre。P． BC．｝ FCS（6） O，89±0．11
（皿，B！） TCCFCS（6） 0．43±0．08＊＊
TCCFCS十pre。P． B．C．（8）078±0。13＊＊




pre。F BC・一 Normal（4） 0．88±0．16
（皿，B，） Prost， Sar，Nomal（4） 0、86＝とG．！8
Prost， Sar，N＋ρre。P．8．C．（7）0，82±0．12
Prost， Sar，N十Pr。5t， Sar，（4）0、81±0．10
B．C ： bladder carcinoma
TCC ： transitional cell car¢inoma
＊ leukocytes reactive










Table 8． Blocking ＆ unblocking effect of serum


















post ep． b］ood samples were taken 3－v6 month＄ after
eperatlon．
 ＊leukocytes reactive， P〈O．OOI
＊＊5erum blocking effect、 PくO．OOI































Table 4． LAI index used autologous antigen
     in postoperative course of bladder




2（皿，C）0．45 0．59 0．76 0．88




7（皿，C） 0．49 0．57 0．31＊＊
8（皿，？） 0．52 0．48 0．85 0．94
9（皿，B1） 0．46 0．38
10（皿，B1）0．51 0．69 0．82
＊ GI grade， S： stage
＊＊Recurrence at PD． 9M．
























Table 5． Blocking ＆ unbiocking effect of serum
     on LAI in postoperative course of bladder
     carclnoma
Serum Donor
 （G， S）
pe iod after operation
IW 4W 3M 6M
      B 一H－1偲B1＞＜
      U －
      B→伸2（皿，c）＜
      U －
3 （M，Bi）〈： t
      B 一H－4（皿A）＜
      U －
      B 十5（豆，？）＜












G， S：grade ＆ stage of bladder carcinoma
B［blocklng effect of serum
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